Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.
about
Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.Should age impact breast cancer management in young women? Fine tuning of treatment guidelines.Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.
P2860
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@en
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@nl
type
label
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@en
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@nl
prefLabel
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@en
Dose-dense adjuvant chemothera ...... G1 and GIM2 phase III studies.
@nl
P2093
P50
P1476
Dose-dense adjuvant chemothera ...... IG1 and GIM2 phase III studies
@en
P2093
Andrea De Censi
Andrea Michelotti
Anna Turletti
Antonio Durando
Claudia Bighin
Enrichetta Valle
Francesco Cognetti
Giancarlo Bisagni
Giovanna Cavazzini
Lucia Del Mastro
P356
10.1016/J.EJCA.2016.10.030
P50
P577
2016-12-10T00:00:00Z